Hoffman Robert E.
Insider CIK 1166288 · ARNA VP, Finance and CFO · MBVX Director · CYDY Chief Financial Officer · CBMX Director · INNV CHIEF FINANCIAL OFFICER · NONE Director · ESPR Director · DMPI President, CEO, and CFO, Director · ARAV Director · FBLG Director · HRTX CFO & SVP, Finance
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CYDY CytoDyn Inc. | A Award deriv | 2026-10-20 | 2026-10-20 | 2,500,000 | — | $0 | 2,500,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | D To issuer deriv | 2026-07-13 | 2026-07-13 | 40,000 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | D To issuer deriv | 2026-07-13 | 2026-07-13 | 7,040 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | D To issuer | 2026-07-13 | 2026-07-13 | 85,153 | — | $0 | 0 | SEC↗ |
| FBLG FibroBiologics, Inc. | A Award deriv | 2026-06-23 | 2026-06-23 | 30,803 | — | $0 | 30,803 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2026-05-28 | 2026-06-01 | 79,873 | — | $0 | 85,153 | SEC↗ |
| CYDY CytoDyn Inc. | A Award deriv | 2026-03-20 | 2026-03-24 | 4,874,691 | — | $0 | 4,874,691 | SEC↗ |
| HURA TuHURA Biosciences, Inc./N | A Award deriv | 2026-02-12 | 2026-02-17 | 156,240 | — | $0 | 156,240 | SEC↗ |
| FBLG FibroBiologics, Inc. | A Award deriv | 2025-06-12 | 2025-06-12 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2025-05-29 | 2025-06-02 | 7,040 | — | $0 | 7,040 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2025-05-29 | 2025-06-02 | 5,280 | — | $0 | 5,280 | SEC↗ |
| CYDY CytoDyn Inc. | A Award deriv | 2025-05-15 | 2025-05-22 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2025-04-01 | 2025-04-02 | 40,000 | — | $0 | 40,000 | SEC↗ |
| HURA TuHURA Biosciences, Inc./N | A Award deriv | 2025-01-02 | 2025-01-06 | 51,275 | — | $0 | 51,275 | SEC↗ |
| FBLG FibroBiologics, Inc. | A Award deriv | 2024-08-27 | 2024-08-27 | 5,000 | — | $0 | 5,000 | SEC↗ |
| KTRA Kintara Therapeutics, Inc. | A Award deriv | 2023-08-30 | 2023-09-01 | 23,142 | — | $0 | 23,142 | SEC↗ |
| KTRA Kintara Therapeutics, Inc. | A Award | 2023-06-01 | 2023-06-02 | 59,800 | — | $0 | 68,902 | SEC↗ |
| KTRA Kintara Therapeutics, Inc. | A Award deriv | 2022-08-01 | 2022-08-03 | 1,200,634 | — | $0 | 1,200,634 | SEC↗ |
| KTRA Kintara Therapeutics, Inc. | A Award | 2022-08-01 | 2022-08-03 | 400,145 | — | $0 | 455,145 | SEC↗ |
| KTRA Kintara Therapeutics, Inc. | P Buy | 2022-02-15 | 2022-02-17 | 55,000 | $0.47 | $25.9K | 55,000 | SEC↗ |
| KTRA Kintara Therapeutics, Inc. | A Award deriv | 2021-11-08 | 2021-11-10 | 3,519,170 | — | $0 | 3,519,170 | SEC↗ |
| KTRA Kintara Therapeutics, Inc. | A Award deriv | 2021-09-22 | 2021-09-22 | 100,000 | — | $0 | 100,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2021-06-22 | 2021-06-23 | 23,000 | — | $0 | 23,000 | SEC↗ |
| KTRA Kintara Therapeutics, Inc. | A Award deriv | 2020-09-15 | 2020-09-17 | 120,000 | — | $0 | 120,000 | SEC↗ |
| DMPI DelMar Pharmaceuticals, In | A Award deriv | 2020-06-26 | 2020-06-30 | 39,567 | — | $0 | 75,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2020-06-24 | 2020-06-26 | 23,000 | — | $0 | 23,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2019-12-19 | 2019-12-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2019-09-12 | 2019-09-13 | 7,500 | — | $0 | 7,500 | SEC↗ |
| DMPI DelMar Pharmaceuticals, In | A Award deriv | 2019-09-05 | 2019-09-09 | 35,433 | — | $0 | 35,433 | SEC↗ |
| DMPI DelMar Pharmaceuticals, In | A Award deriv | 2019-09-05 | 2019-09-09 | 39,567 | — | $0 | 39,567 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2019-06-25 | 2019-06-27 | 13,000 | — | $0 | 13,000 | SEC↗ |
| DMPI DelMar Pharmaceuticals, In | D To issuer deriv | 2019-04-30 | 2019-05-01 | 200,000 | — | $0 | 0 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2019-01-03 | 2019-01-07 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2019-01-03 | 2019-01-07 | 4,688 | — | $0 | 4,688 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2019-01-03 | 2019-01-07 | 4,688 | — | $0 | 4,688 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2019-01-03 | 2019-01-07 | 7,500 | — | $0 | 7,500 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2018-12-15 | 2018-12-18 | 71,000 | — | $0 | 71,000 | SEC↗ |
| DMPI DelMar Pharmaceuticals, In | A Award deriv | 2018-11-08 | 2018-11-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise deriv | 2018-07-02 | 2018-07-03 | 30,000 | — | $0 | 100,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2018-07-02 | 2018-07-03 | 28,940 | $38.15 | $1.10M | 2,340 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | M Exercise | 2018-07-02 | 2018-07-03 | 30,000 | $15.30 | $459.0K | 31,280 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | S Sale | 2018-07-02 | 2018-07-03 | 1,060 | $38.80 | $41.1K | 1,280 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2018-06-07 | 2018-06-08 | 13,000 | — | $0 | 13,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2018-04-30 | 2018-07-03 | 744 | $13.22 | $9.8K | 1,280 | SEC↗ |
| DMPI DelMar Pharmaceuticals, In | A Award deriv | 2018-04-13 | 2018-04-17 | 36,000 | — | $0 | 36,000 | SEC↗ |
| DMPI DelMar Pharmaceuticals, In | A Award deriv | 2018-04-13 | 2018-04-17 | 200,000 | — | $0 | 200,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2017-12-18 | 2017-12-20 | 56,667 | — | $0 | 56,667 | SEC↗ |
| CBMX CombiMatrix Corp | U Tender deriv | 2017-11-14 | 2017-11-16 | 1,619 | — | $0 | 0 | SEC↗ |
| CBMX CombiMatrix Corp | D To issuer | 2017-11-14 | 2017-11-16 | 2,001 | — | $0 | 6,618 | SEC↗ |
| CBMX CombiMatrix Corp | U Tender | 2017-11-14 | 2017-11-16 | 6,618 | — | $0 | 0 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | J Other | 2017-10-31 | 2017-12-20 | 536 | $13.05 | $7.0K | 536 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2017-06-09 | 2017-06-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | A Award deriv | 2017-05-19 | 2017-05-23 | 50,000 | $1.80 | $90.0K | 50,000 | SEC↗ |
| HRTX HERON THERAPEUTICS, INC. / | A Award deriv | 2017-04-24 | 2017-04-24 | 130,000 | — | $0 | 130,000 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | M Exercise deriv | 2017-04-02 | 2017-04-04 | 1,543 | — | $0 | 1,543 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | M Exercise | 2017-04-02 | 2017-04-04 | 1,543 | — | $0 | 4,438 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | A Award deriv | 2017-01-01 | 2017-01-03 | 4,100 | $3.38 | $13.9K | 4,100 | SEC↗ |
| INNV INNOVUS PHARMACEUTICALS, I | A Award deriv | 2016-09-06 | 2016-11-21 | 2,500,000 | $0.27 | $675.0K | 2,500,000 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | A Award deriv | 2016-08-29 | 2016-08-30 | 4,100 | $5.00 | $20.5K | 4,100 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | A Award deriv | 2016-06-29 | 2016-07-28 | 35,000 | $0.55 | $19.3K | 35,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2016-05-12 | 2016-05-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CBMX CombiMatrix Corp | P Buy | 2016-05-10 | 2016-05-10 | 5,000 | $3.19 | $15.9K | 7,409 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | M Exercise deriv | 2016-04-04 | 2016-04-05 | 11,417 | — | $0 | 22,833 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | M Exercise | 2016-04-04 | 2016-04-05 | 11,417 | — | $0 | 21,417 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | A Award deriv | 2015-08-26 | 2015-08-27 | 35,000 | $1.52 | $53.2K | 35,000 | SEC↗ |
| NONE Kura Oncology, Inc. | A Award deriv | 2015-04-23 | 2015-04-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | A Award deriv | 2015-04-02 | 2015-04-03 | 34,250 | $2.30 | $78.8K | 34,250 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | A Award deriv | 2015-04-02 | 2015-04-03 | 34,250 | — | $0 | 34,250 | SEC↗ |
| CBMX CombiMatrix Corp | A Award | 2015-01-09 | 2015-01-13 | 12,528 | — | $0 | 54,295 | SEC↗ |
| CBMX CombiMatrix Corp | A Award deriv | 2015-01-02 | 2015-01-06 | 2,000 | — | $0 | 2,000 | SEC↗ |
| MBVX MABVAX THERAPEUTICS HOLDIN | P Buy | 2014-12-16 | 2014-12-17 | 10,000 | $2.40 | $24.0K | 21,116 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2014-12-15 | 2014-12-17 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award | 2014-12-15 | 2014-12-17 | 15,000 | — | $0 | 58,074 | SEC↗ |
| CBMX CombiMatrix Corp | A Award | 2014-02-20 | 2014-02-24 | 17,495 | — | $0 | 41,767 | SEC↗ |
| CBMX CombiMatrix Corp | C Conversion deriv | 2013-12-20 | 2013-12-20 | 50 | — | $0 | 0 | SEC↗ |
| CBMX CombiMatrix Corp | C Conversion | 2013-12-20 | 2013-12-20 | 24,272 | — | $0 | 24,272 | SEC↗ |
| CBMX CombiMatrix Corp | P Buy deriv | 2013-12-19 | 2013-12-20 | 50 | — | $0 | 24,272 | SEC↗ |
| CBMX CombiMatrix Corp | P Buy deriv | 2013-12-19 | 2013-12-20 | 50 | — | $0 | 24,272 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2013-12-17 | 2013-12-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award | 2013-12-17 | 2013-12-18 | 20,000 | — | $0 | 40,820 | SEC↗ |
| CBMX CombiMatrix Corp | A Award deriv | 2013-07-15 | 2013-07-17 | 2,000 | — | $0 | 2,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise deriv | 2013-04-01 | 2013-04-03 | 71,250 | — | $0 | 213,750 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | S Sale | 2013-04-01 | 2013-04-03 | 71,250 | $8.21 | $585.0K | 19,570 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise | 2013-04-01 | 2013-04-03 | 71,250 | $1.81 | $129.0K | 90,820 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2012-12-13 | 2012-12-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award | 2012-12-13 | 2012-12-17 | 15,000 | — | $0 | 18,382 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise deriv | 2012-10-01 | 2012-10-02 | 50,000 | — | $0 | 150,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | S Sale | 2012-10-01 | 2012-10-02 | 50,000 | $8.32 | $416.0K | 3,382 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | M Exercise | 2012-10-01 | 2012-10-02 | 50,000 | $1.48 | $74.0K | 53,382 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | S Sale | 2012-07-05 | 2012-07-09 | 10,000 | $11.00 | $110.0K | 2,763 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | A Award deriv | 2012-03-19 | 2012-03-19 | 285,000 | — | $0 | 285,000 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | J Other | 2012-01-06 | 2012-01-10 | 150 | $1.64 | $246 | 12,294 | SEC↗ |
| ARNA ARENA PHARMACEUTICALS INC | J Other | 2012-01-06 | 2012-01-10 | 150 | $1.63 | $244 | 12,144 | SEC↗ |